Clinical Trials Browser

Withdrawn × Melanoma × Panobinostat × Clear all

NCT03982134 2019-10-04

PDR001 + Panobinostat for Melanoma and NSCLC

Phase 1 Withdrawn

DermatologicThoracic

Carcinoma, Non-Small-Cell Lung, Melanoma